Abstract: Wireless sensing devices including stable near-field antennas are provided. A spacer layer is attached to a portion of the substrate adjacent to the antenna. The spacer layer has a thickness T, a relative permittivity k, and a figure of merit defined as the ratio of T (in micrometers) by k. The spacer layer has the figure of merit no less than 20 (micrometers).

Abstract: Wireless sensing devices including stable near-field antennas are provided. A spacer layer is attached to a portion of the substrate adjacent to the antenna. The spacer layer has a thickness T, a relative permittivity k, and a figure of merit defined as the ratio of T (in micrometers) by k. The spacer layer has the figure of merit no less than 20 (micrometers).

Abstract: A novel device for the delivery of one or more active agents to a subject is disclosed. The device includes a water-soluble or water-dispersible polymeric carrier, an adhesive, one or more active agents and a support layer. Methods of manufacturing and use of said device also are disclosed.

Abstract: A therapeutic agent delivery device has a texturized protective backing, preferably with three-dimensional surface features. By providing the drug delivery device with such a texturized backing, several advantageous properties are imparted to the device, e.g., enhanced ability to camouflage wrinkles and swelling, greater permeability of the backing to water vapor and oxygen, improved flexibility and conformability, and thus, enhanced comfort for the host wearing the device.

Abstract: A therapeutic agent delivery device can be applied onto a host in order to therapeutically administer a therapeutically active agent to the host, wherein the device incorporates a reflective optical film. Use of reflective optical films in patch devices allows a wide variety of visual elements to be incorporated into these devices without relying upon any colorants, dyes, inks, toners, or other materials. These visual effects include logos, high reflectivity, iridescence, graphics, printed information, surface microstructure, bar codes, color, designs, and/or the like. The present invention also improves the barrier qualities of patch drug devices, prolonging shelf life. This enhanced barrier protection is desirable for all patch therapeutic agent delivery devices, but is particularly beneficial for devices containing fluid reservoirs in which the therapeutically active agent(s) might be stored.

Abstract: Optically pure S(+) flurbiprofen, which is substantially free of the R(-) enantiomer, is a potent analgesic for relieving pain and inflammation in humans and animals. A method and composition is disclosed utilizing the optically pure S(+) enantiomer of flurbiprofen for treating pain and inflammation.

Abstract: Polymer blends containing a very low density polyethylene copolymer of ethylene and 1-butene, 1-hexene, or 1-octene and about 15 to about 600 parts by weight of a linear low density polyethylene copolymer of ethylene and 1-octene, based on 100 parts by weight of the very low density polyethylene copolymer.

Abstract: Polymer blends containing a very low density polyethylene copolymer of ethylene and 1-butene, 1-hexene, or 1-octene and about 15 to about 600 parts by weight of a linear low density polyethylene copolymer of ethylene and 1-octene, based on 100 parts by weight of the very low density polyethylene copolymer.